Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Bloom Health Partners announces new Chicago location, closes final tranche of placement for gross proceeds of C$75,000

"Our Chicago presence will support our growth plans in one of America's busiest business regions," said Bloom CEO Andrew Morton

Bloom Health Partners Inc (CSE:BLMH, OTCQB:BLMHF) has announced the opening of a new location in the Chicago area that includes a local team and expanded laboratories for operational health services and diagnostic testing.

The leading workplace healthcare technology provider said the Chicago location will serve film and TV productions in addition to new opportunities with Fortune 500 and other organizations in the surrounding area.

"Our Chicago presence will support our growth plans in one of America's busiest business regions," Bloom Health CEO Andrew Morton said in a statement. "We're focused on growing occupational health-tech for our clients.”

READ: Bloom Health Partners closes second tranche of its previously announced non-brokered private placement for gross proceeds of C$554,000

“With supporting facilities in key hub cities like Dallas, Atlanta and now Chicago, Bloom is well-positioned to support current and future clients in strategic markets," he added.

Completes private placement offering

Bloom also said it has closed the third and final tranche of its previously-announced non-brokered private placement offering and has issued 375,000 units at $0.20 each, raising gross proceeds of C$75,000 for a combined total of C$1,659,000 comprising 8,295,000 units.

The units are comprised of one common share in the company and one-half of a transferable common share purchase warrant that entitles the holder to acquire an additional common share at $0.30 per warrant share until December 26, 2023.

Bloom Health said it will use net proceeds from the offering for ongoing working capital and corporate development.

In connection with the third tranche of the offering, the company said it paid C$4,500 and issued 22,500 warrants, exercisable at $0.30 per warrant share until December 26, 2023, to an arms-length party who assisted in introducing subscribers to the offering.

All securities issued in connection with the offering are subject to a statutory hold period until December 26, 2022, in accordance with applicable securities laws, it added.

Bloom Health is a global platform for healthcare security, diagnostic testing and occupational health-tech. Its mission is to ensure that "unstoppable is possible" for businesses and their employees through innovative, customized healthcare models.

The company offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Its stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes.

Contact the author at jon.hopkins@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK